GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,542,383,000 | +81120.8% | 16,330,430 | +37355.1% | 1.47% | +146600.0% |
| Q1 2022 | $1,899,000 | -72.5% | 43,600 | -72.1% | 0.00% | -85.7% |
| Q4 2021 | $6,901,000 | +29.6% | 156,500 | +12.3% | 0.01% | +75.0% |
| Q3 2021 | $5,324,000 | +741.1% | 139,300 | +776.8% | 0.00% | +300.0% |
| Q2 2021 | $633,000 | +97.2% | 15,888 | +77.7% | 0.00% | – |
| Q1 2021 | $321,000 | -78.3% | 8,939 | -77.8% | 0.00% | – |
| Q4 2020 | $1,479,000 | -55.7% | 40,189 | -54.6% | 0.00% | -100.0% |
| Q3 2020 | $3,337,000 | +181.4% | 88,578 | +202.9% | 0.00% | +50.0% |
| Q2 2020 | $1,186,000 | +23.9% | 29,244 | +43.6% | 0.00% | +100.0% |
| Q4 2019 | $957,000 | – | 20,369 | +185072.7% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 11 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $2,090,000 | +203.8% | 50,000 | +177.5% | 0.00% | – |
| Q4 2018 | $688,000 | -62.8% | 18,019 | -60.8% | 0.00% | -100.0% |
| Q3 2018 | $1,848,000 | -83.2% | 46,000 | -83.1% | 0.00% | -87.5% |
| Q2 2018 | $10,989,000 | +1285.8% | 272,600 | +1242.9% | 0.02% | +1500.0% |
| Q1 2018 | $793,000 | +39550.0% | 20,300 | +36150.0% | 0.00% | – |
| Q4 2017 | $2,000 | -99.9% | 56 | -99.8% | 0.00% | -100.0% |
| Q3 2017 | $1,336,000 | -65.7% | 32,900 | -64.4% | 0.00% | -75.0% |
| Q1 2017 | $3,896,000 | +55.7% | 92,400 | +42.2% | 0.01% | +60.0% |
| Q4 2016 | $2,503,000 | -30.9% | 65,000 | -22.6% | 0.01% | -28.6% |
| Q3 2016 | $3,622,000 | -45.4% | 84,000 | -48.9% | 0.01% | -50.0% |
| Q4 2015 | $6,637,000 | -39.2% | 164,492 | -42.1% | 0.01% | -41.7% |
| Q3 2015 | $10,924,000 | -32.5% | 284,100 | -26.8% | 0.02% | -29.4% |
| Q2 2015 | $16,174,000 | +598.1% | 388,300 | +673.5% | 0.03% | +580.0% |
| Q1 2015 | $2,317,000 | +436.3% | 50,200 | +397.0% | 0.01% | +400.0% |
| Q4 2014 | $432,000 | -94.6% | 10,100 | -93.2% | 0.00% | -97.4% |
| Q4 2013 | $7,962,000 | +29.5% | 149,138 | +21.7% | 0.04% | +21.9% |
| Q3 2013 | $6,150,000 | +18.5% | 122,581 | +18.0% | 0.03% | +33.3% |
| Q2 2013 | $5,192,000 | – | 103,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |